AR030095A1 - Composicion farmaceutica que contiene citalopram - Google Patents

Composicion farmaceutica que contiene citalopram

Info

Publication number
AR030095A1
AR030095A1 ARP010103662A ARP010103662A AR030095A1 AR 030095 A1 AR030095 A1 AR 030095A1 AR P010103662 A ARP010103662 A AR P010103662A AR P010103662 A ARP010103662 A AR P010103662A AR 030095 A1 AR030095 A1 AR 030095A1
Authority
AR
Argentina
Prior art keywords
citalopram
pharmaceutical composition
composition containing
pharmaceutically acceptable
containing citalopram
Prior art date
Application number
ARP010103662A
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR030095(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR030095A1 publication Critical patent/AR030095A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010103662A 2000-08-10 2001-07-31 Composicion farmaceutica que contiene citalopram AR030095A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (1)

Publication Number Publication Date
AR030095A1 true AR030095A1 (es) 2003-08-13

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103662A AR030095A1 (es) 2000-08-10 2001-07-31 Composicion farmaceutica que contiene citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (cs)
JP (1) JP2003531153A (cs)
KR (1) KR20030024833A (cs)
CN (1) CN1446089A (cs)
AR (1) AR030095A1 (cs)
AT (1) AT5744U1 (cs)
AU (2) AU2001100198B4 (cs)
BE (1) BE1013559A6 (cs)
BG (1) BG107578A (cs)
BR (1) BR0113250A (cs)
CA (1) CA2353693C (cs)
CH (2) CH694242A5 (cs)
CZ (1) CZ2003397A3 (cs)
DE (2) DE10139115A1 (cs)
EA (1) EA200300247A1 (cs)
ES (1) ES2172481B2 (cs)
FI (1) FI5176U1 (cs)
FR (1) FR2812811B1 (cs)
GB (1) GB2368014B (cs)
GR (1) GR1004193B (cs)
HR (1) HRP20030054A2 (cs)
HU (1) HUP0103071A3 (cs)
IE (1) IES20010693A2 (cs)
IL (1) IL154050A0 (cs)
IS (1) IS6021A (cs)
IT (1) ITMI20011637A1 (cs)
MX (1) MXPA03000837A (cs)
NL (1) NL1018741C1 (cs)
NO (1) NO20013891L (cs)
NZ (1) NZ523785A (cs)
PL (1) PL359824A1 (cs)
SK (1) SK2842003A3 (cs)
WO (1) WO2001080619A2 (cs)
YU (1) YU9003A (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
DK1578738T3 (da) * 2002-12-23 2008-06-30 Lundbeck & Co As H Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106397249A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种高稳定性lcz696结晶粉末及其制备方法
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form
WO2024165628A1 (en) 2023-02-07 2024-08-15 Kinast Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
WO2001080619A3 (en) 2002-02-21
NL1018741C1 (nl) 2002-02-12
HUP0103071A3 (en) 2002-12-28
JP2003531153A (ja) 2003-10-21
AU2001100198A4 (en) 2001-08-16
IL154050A0 (en) 2003-07-31
WO2001080619A2 (en) 2001-11-01
BR0113250A (pt) 2003-06-24
NO20013891D0 (no) 2001-08-09
YU9003A (sh) 2006-05-25
NZ523785A (en) 2004-09-24
DE20113195U1 (de) 2001-11-15
EA200300247A1 (ru) 2003-06-26
FR2812811A1 (fr) 2002-02-15
AU2001100198B4 (en) 2002-06-13
CN1446089A (zh) 2003-10-01
CH694241A5 (de) 2004-10-15
BE1013559A6 (fr) 2002-03-05
MXPA03000837A (es) 2003-06-06
FR2812811B1 (fr) 2006-08-18
CA2353693C (en) 2003-07-22
EP1318805A2 (en) 2003-06-18
ES2172481B2 (es) 2004-08-01
HU0103071D0 (en) 2001-10-28
GR20010100377A (el) 2002-09-06
ES2172481A1 (es) 2002-09-16
GR1004193B (el) 2003-03-24
BG107578A (bg) 2003-09-30
PL359824A1 (en) 2004-09-06
CH694242A5 (de) 2004-10-15
DE10139115A1 (de) 2002-03-28
HUP0103071A2 (hu) 2002-05-29
FI5176U1 (fi) 2001-12-27
KR20030024833A (ko) 2003-03-26
AT5744U1 (de) 2002-11-25
CA2353693A1 (en) 2002-01-22
NO20013891L (no) 2002-02-11
IES20010693A2 (en) 2002-07-10
GB2368014A (en) 2002-04-24
AU2001279591A1 (en) 2001-11-07
ITMI20011637A1 (it) 2003-01-27
GB2368014B (en) 2004-06-23
ITMI20011637A0 (it) 2001-07-27
IS6021A (is) 2001-10-20
SK2842003A3 (en) 2003-09-11
CZ2003397A3 (cs) 2003-06-18
HRP20030054A2 (en) 2005-02-28
GB0118579D0 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
AR030095A1 (es) Composicion farmaceutica que contiene citalopram
AR049000A1 (es) Formulacion para compresion directa y proceso para la preparacion de una tableta directamente comprimida
CO5011053A1 (es) Procedimiento para la produccion de una forma de dosificacion solida que contiene carvedilol e hidroclorotiazida y formas farmaceuticas obtenidas por dicho procedimiento
CO5611118A2 (es) Formulaciones de azitromicina granuladas por via seca
CO5190688A1 (es) Formas farmaceuticas de administracion oral al menos parcialmente retardadas cuya sustancia activa tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad 100 mg/ml, y procedimientos para su preparac
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
AR010634A1 (es) Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
CO5390076A1 (es) Composiciones farmaceuticas
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
AR033688A1 (es) Composicion parenteral reconstituible
AR038143A1 (es) Agonistas del receptor 2 del factor liberador de la corticotropina
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
BRPI0512756A (pt) composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
AR039221A1 (es) Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas
BRPI0509971A (pt) uma forma de dosagem farmacêutica, comprimido e método de preparação
CO5261595A1 (es) Composiciones farmaceuticas que contienen una combinacion de salmeterol e ipratropium
ECSP088647A (es) Nueva sal de citrato de un derivado de indol y su uso farmacéutico
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
AR043019A1 (es) Formas de dosificacion solida transmucosal oral libres de azucar y sus usos
BR0307816C1 (pt) composição farmacêutica oral para cápsulas macias contendo vinorelbina e método de tratamento
CO5170463A1 (es) Formas polimorfas de un citrato de azobiciclo [2,2,2]octan- 3-amina y sus composiciones farmaceuticas
CO5700697A2 (es) Forma de dosis solida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal